Back to Gene
HDAC8 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

HDAC8 gene

The HDAC8 gene provides instructions for making an enzyme that regulates chromosome structure and gene activity, with variants linked to developmental disorders like Cornelia de Lange syndrome.

Normal Function

The HDAC8 gene provides instructions for making an enzyme called histone deacetylase 8. This enzyme is involved in regulating the structure and organization of chromosomes during cell division.

Before cells divide, they must copy all of their chromosomes. The copied DNA from each chromosome is arranged into two identical structures called sister chromatids. Sister chromatids are attached to one another during the early stages of cell division by a group of proteins called the cohesin complex. Later in cell division, the cohesin complex must be removed so the sister chromatids can separate, allowing one from each pair to move into each newly forming cell. Histone deacetylase 8 carries out a chemical reaction that helps remove the cohesin complex so it can be recycled for future cell divisions.

Researchers believe that histone deacetylase 8, as a regulator of the cohesin complex, also plays important roles in stabilizing cells' genetic information, repairing damaged DNA, and controlling the activity of certain genes that are essential for normal development.

Health Conditions Related to Genetic Changes

Cornelia de Lange syndrome

Variants (also called mutations) in the HDAC8 gene have been identified in people with Cornelia de Lange syndrome, a developmental disorder that affects many parts of the body. Researchers estimate that variants in this gene account for about 5 percent of all cases of this condition.

Most HDAC8 gene variants change single protein building blocks (amino acids) in histone deacetylase 8 or add or delete a small number of amino acids in the enzyme. All of these variants appear to reduce or eliminate the enzyme's activity, which likely alters the activity of the cohesin complex and impairs its ability to regulate genes that are critical for normal development. Although researchers do not fully understand how these changes cause Cornelia de Lange syndrome, they suspect that altered gene regulation probably underlies many of the developmental problems characteristic of the condition.

Studies suggest that variants in the HDAC8 gene cause a somewhat different pattern of signs and symptoms than those associated with variants in the NIPBL gene, which are the most common known cause of Cornelia de Lange syndrome. Affected individuals with HDAC8 gene variants often have:

  • Less severe growth problems
  • Fewer abnormalities of the arms and hands
  • Different characteristic facial features
  • Delayed closure of the "soft spot" on the head (the anterior fontanelle) in infancy
  • Widely spaced eyes (hypertelorism)
  • Dental abnormalities
  • Significant intellectual disability

Other disorders

A variant in the HDAC8 gene has also been identified in a large Dutch family with a form of X-linked intellectual disability. Signs and symptoms in affected males include severe intellectual disability, short stature, obesity, breast enlargement (gynecomastia), reduced production of sex hormones (hypogonadism), an unusually small head (microcephaly), small hands, and distinctive facial features. Affected females tend to have less severe signs and symptoms, including learning disabilities and unusual facial features.

The identified variant leads to a version of histone deacetylase 8 that is missing a segment. The abnormally short protein probably alters gene regulation during development, which causes the various health problems described in this family. While this condition has been described as Wilson-Turner syndrome, researchers speculate that it may actually be part of the same disease spectrum as Cornelia de Lange syndrome.

Other Names for This Gene

  • CDA07
  • CDLS5
  • HD8
  • HDACL1
  • histone deacetylase-like 1
  • MRXS6
  • RPD3
  • WTS

Frequently Asked Questions

There is currently no cure or specific gene therapy for HDAC8-related Cornelia de Lange syndrome. Management is supportive and focuses on addressing individual symptoms through a multidisciplinary approach. This may include physical and occupational therapy to improve motor skills, speech therapy for communication challenges, and educational support tailored to the individual's cognitive abilities. Regular monitoring for associated health issues, such as heart defects or gastrointestinal problems, is also essential for long-term care.
Most cases of Cornelia de Lange syndrome linked to the HDAC8 gene are caused by de novo (new) mutations, meaning they occur spontaneously in the egg or sperm cell or in the early embryo and are not inherited from a parent. Because these are usually new mutations, the recurrence risk for future pregnancies is generally low, typically estimated at around 1 to 2 percent, although it is not zero. Genetic counseling is recommended to assess specific family history and recurrence risks accurately.
Individuals with HDAC8-related Cornelia de Lange syndrome often present with a range of developmental and physical features, including growth delays (short stature), intellectual disability, and characteristic facial features such as a small mouth, thin upper lip, and downward-slanting eyes. Other common signs include limb abnormalities, such as missing or shortened fingers or toes, and potential heart defects. The severity of these symptoms can vary significantly between individuals, even within the same family.
Yes, genetic testing for the HDAC8 gene is a standard part of the diagnostic workup for Cornelia de Lange syndrome, particularly when clinical features are present. Since HDAC8 variants account for about 5 percent of all cases, testing is often performed alongside other genes known to cause the syndrome, such as NIPBL and SMC1A. A positive result confirms the genetic basis of the condition, while a negative result does not rule out the syndrome, as other genetic causes exist.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA